Following the passage of a marijuana legalization bill on Thursday by New Hampshire’s House of Representatives, Gov. Chris Sununu (R) is signaling that he’s against the legislation in its current form but could still ultimately get on board if changes are made in the Senate. The comments from the... Read more
The Justice Department is investigating marijuana-related businesses that allegedly took coronavirus relief loans in violation of federal rules, with third-party actors leveraging a whistleblower policy that allows them to take a portion of settlement money if they report on the cannabis companies. Multiple sources in the cannabis legal space... Read more
A Vermont Senate panel this week discussed planned changes to a House-passed bill that would, in its current form, create and fund two overdose prevention centers in the state, where people could use currently prohibited substances in a medically supervised environment—part of a pilot program aimed at quelling the... Read more
The head of the Food and Drug Administration (FDA) says there’s “no reason” for the Drug Enforcement Administration (DEA) to “delay” making a marijuana scheduling decision. FDA Commissioner Robert Califf also said that, “as a child of the sixties,” it would “be nice if in my lifetime we came... Read more
“The Cannabis Commission has had three years to get this program going and it’s still dead in the water.” By Alander Rocha, Alabama Reflector An Alabama Senate committee Wednesday approved two bills aimed at restarting the state’s medical cannabis licensing process. The Senate Agriculture, Conservation, and Forestry Committee approved... Read more
New Hampshire’s House of Representatives has approved a bill to legalize and regulate marijuana in the state and set strict limits on advertising and marketing. The legislation, from Rep. Erica Layon (R), next proceeds to the Senate, where many expect it will receive a cold welcome for departing from... Read more
Ohio marijuana sales could launch as soon as June under a regulatory plan that a legislative rulemaking committee is set to approve as lawmakers’ plans to revise the voter-approved legalization law continue to stall out. Regulators have until September to start issuing cannabis business licenses under the ballot initiative... Read more
Single-dose psilocybin use is “not associated with risk of paranoia,” while other adverse effects such as headaches are generally “tolerable and resolved within 48 hours”—according to a new scientific review published by the American Medical Association (AMA). With increased public interest in the therapeutic potential of psychedelics, researchers at... Read more
The number of full-time marijuana jobs in the U.S. rose by nearly 5 percent during the past year, according to the latest annual industry report on employment in the cannabis sector. That’s a turnaround from the roughly 2 percent decline between 2022 and 2023, but otherwise it marks the... Read more
